EEF2K and neoplasm: The impact of eEF-2K expression on the cytocidal activity of CD8+ T cells was further validated by the experiments demonstrating that augmenting eEF-2K in tumor Ag-specific CD8+ T cells enhanced the antitumor efficacy of CTLs and improved their functionality (Fig. 5, C and D).